Lumida
/INVA
⌘K
Innoviva Inc

Innoviva Inc

INVA
$20.66USD↑+0.19%+0.04 today

MARKET CAP

1.5B

P/E (TTM)

3.4x

FWD P/E

—

DAY RANGE

$20 – $21

52W RANGE

$17
$25

AI Summary

Stalk
TrimMedium

In Stage 4 decline with price below all major EMAs and failed stabilization attempts, medium-term bearish bias prevails. Short-term timing remains neutral after a bounce off support without follow-through. Given the Stable strategy’s emphasis on cautious, range-based interaction, trimming into rallies at EMA resistance is advised.

  • ↑High profitability metrics indicate efficient operations and expanding margins.
  • ↑Earnings yield above peers suggests attractive valuation entry point.
  • ↓Sub-1% dividend yield undermines shareholder income appeal.
Full analysis →
Insider Trades29 trades
Date↓SideTicker↕Insider↕Role↕Shares↕Price↕Mkt Cap↕52W High↕52W Low↕Value↕% Chg↕Rule↕AI View↕
May 20, 2026SellINVAStephen BassoChief Financial Officer559$22.24$1.5B-17.84%+25.06%$12.4K-0.63%—Sell Now
May 20, 2026SellINVAMarianne ZhenChief Accounting Officer1,127$22.24$1.5B-17.84%+25.06%$25.1K-1.92%—Sell Now
May 20, 2026SellINVAPavel RaifeldChief Executive Officer1,130$22.24$1.5B-17.84%+25.06%$25.1K-0.39%—Sell Now
Feb 20, 2026SellINVAStephen BassoChief Financial Officer1,244$23.39$1.5B-17.84%+25.06%$29.1K-2.43%—Sell Now
Feb 20, 2026SellINVAMarianne ZhenChief Accounting Officer2,460$23.39$1.5B-17.84%+25.06%$57.5K-5.09%—Sell Now
Feb 20, 2026SellINVAPavel RaifeldChief Executive Officer2,986$23.39$1.5B-17.84%+25.06%$69.8K-1.84%—Sell Now
Nov 20, 2025SellINVAStephen BassoChief Financial Officer237$21.16$1.5B-17.84%+25.06%$5.0K-0.46%—Sell Now
Nov 20, 2025SellINVAMarianne ZhenChief Accounting Officer992$21.16$1.5B-17.84%+25.06%$21.0K-2.01%—Sell Now
Nov 3, 2025BuyINVAStephen BassoChief Financial Officer27,609$18.11$1.5B-17.84%+25.06%$500.0K+118.59%—Sell Now
Aug 20, 2025SellINVAStephen BassoChief Financial Officer237$19.95$1.5B-17.84%+25.06%$4.7K-1.01%—Sell Now
Aug 20, 2025SellINVAMarianne ZhenChief Accounting Officer991$19.95$1.5B-17.84%+25.06%$19.8K-1.97%—Sell Now
May 20, 2025SellINVAStephen BassoChief Financial Officer237$18.78$1.5B-17.84%+25.06%$4.5K-1.00%—Sell Now
May 20, 2025SellINVAMarianne ZhenChief Accounting Officer992$18.78$1.5B-17.84%+25.06%$18.6K-1.93%—Sell Now
Feb 24, 2025BuyINVAMarianne ZhenChief Accounting Officer8,938$18.08$1.5B-17.84%+25.06%$161.6K+6.59%—Sell Now
Feb 24, 2025BuyINVAStephen BassoChief Financial Officer10,569$18.08$1.5B-17.84%+25.06%$191.1K+3.66%—Sell Now
Feb 20, 2025SellINVAStephen BassoChief Financial Officer1,106$18.07$1.5B-17.84%+25.06%$20.0K-8.55%—Sell Now
Feb 20, 2025SellINVAMarianne ZhenChief Accounting Officer2,565$18.07$1.5B-17.84%+25.06%$46.3K-5.71%—Sell Now
Nov 20, 2024SellINVAMarianne ZhenChief Accounting Officer976$19.15$1.5B-17.84%+25.06%$18.7K-2.13%—Sell Now
Aug 20, 2024SellINVAMarianne ZhenChief Accounting Officer975$18.49$1.5B-17.84%+25.06%$18.0K-2.09%—Sell Now
May 20, 2024SellINVAMatthew Ronsheim—268$16.13$1.5B-17.84%+25.06%$4.3K-0.66%—Sell Now
May 20, 2024SellINVAMarianne ZhenChief Accounting Officer976$16.13$1.5B-17.84%+25.06%$15.7K-2.05%—Sell Now
Mar 5, 2024BuyINVAMarianne ZhenChief Accounting Officer10,752$14.88$1.5B-17.84%+25.06%$160.0K+10.77%—Sell Now
Mar 5, 2024BuyINVAStephen BassoChief Financial Officer12,096$14.88$1.5B-17.84%+25.06%$180.0K+6.88%—Sell Now
Mar 5, 2024BuyINVAMatthew Ronsheim—12,768$14.88$1.5B-17.84%+25.06%$190.0K+8.60%—Sell Now
Feb 20, 2024SellINVAMatthew Ronsheim—807$15.80$1.5B-17.84%+25.06%$12.8K-2.80%—Sell Now
Feb 20, 2024SellINVAMarianne ZhenChief Accounting Officer2,862$15.80$1.5B-17.84%+25.06%$45.2K-7.21%—Sell Now
Jan 18, 2024SellINVAMatthew Ronsheim—1,600$16.05$1.5B-17.84%+25.06%$25.7K-1.30%—Sell Now
Nov 20, 2023SellINVAMarianne ZhenChief Accounting Officer784$13.62$1.5B-17.84%+25.06%$10.7K-1.94%—Sell Now
Nov 15, 2023SellINVAMarianne ZhenChief Accounting Officer10,994$13.99$1.5B-17.84%+25.06%$153.8K-11.37%—Sell Now